Does PALBOCICLIB Cause Product dose omission in error? 592 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 592 reports of Product dose omission in error have been filed in association with PALBOCICLIB (Ibrance). This represents 0.7% of all adverse event reports for PALBOCICLIB.
592
Reports of Product dose omission in error with PALBOCICLIB
0.7%
of all PALBOCICLIB reports
11
Deaths
60
Hospitalizations
How Dangerous Is Product dose omission in error From PALBOCICLIB?
Of the 592 reports, 11 (1.9%) resulted in death, 60 (10.1%) required hospitalization, and 3 (0.5%) were considered life-threatening.
Is Product dose omission in error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 592 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Product dose omission in error?
DUPILUMAB (7,586)
TOFACITINIB (2,461)
LENALIDOMIDE (618)
DIROXIMEL (481)
ABALOPARATIDE (457)
NIRAPARIB (428)
RUXOLITINIB (425)
TERIFLUNOMIDE (371)
DIMETHYL (308)
RELUGOLIX (293)
Which PALBOCICLIB Alternatives Have Lower Product dose omission in error Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID